← Back to Clinical Trials
Recruiting NCT06551714

NCT06551714 The Effect of Neurophysiological Facilitation Techniques on Health Parameters in Early Stages After Open Heart Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06551714
Status Recruiting
Phase
Sponsor Dogus Universitesi
Condition Open Heart Surgery
Study Type INTERVENTIONAL
Enrollment 32 participants
Start Date 2024-01-01
Primary Completion 2024-10-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
Phase 1 cardiac rehabilitationNeurophysiological facilitation techniques

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 32 participants in total. It began in 2024-01-01 with a primary completion date of 2024-10-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In this study, researchers aimed to investigate effects of neurophysiological facilitation on functional capacity and respiratory parameters of patients who underwent open heart surgery. Do neurophysiological facilitation techniques improve individuals' respiratory parameters more than phase 1 cardiac rehabilitation? Do neurophysiological facilitation techniques improve individuals' functional capacity more than phase 1 cardiac rehabilitation? Researchers will apply phase 1 cardiac rehabilitation to both groups to see the effectiveness of neurophysiological facilitation techniques.

Eligibility Criteria

Inclusion Criteria: * Having open heart surgery for the first time, * Being between the ages of 18-75, * Being fully cooperative Exclusion Criteria: * Having facial, sternum and rib fractures, * Having chronic renal failure, * Development of cerebrovascular accident, * Having cognitive dysfunction, * Development of deep vein thrombosis in the post-operative period, * Having neuromuscular disease, * Having an orthopedic disability, * Intubation time longer than 24 hours, * Staying in intensive care for more than 48 hours

Contact & Investigator

Central Contact

Feyza merakli

✉ feyzamrkl@gmail.com

📞 05427685223

Principal Investigator

Yasemin Cirak, Prof. Dr.

PRINCIPAL INVESTIGATOR

Istinye University

Frequently Asked Questions

Who can join the NCT06551714 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Open Heart Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06551714 currently recruiting?

Yes, NCT06551714 is actively recruiting participants. Contact the research team at feyzamrkl@gmail.com for enrollment information.

Where is the NCT06551714 trial being conducted?

This trial is being conducted at Ankara, Turkey (Türkiye).

Who is sponsoring the NCT06551714 clinical trial?

NCT06551714 is sponsored by Dogus Universitesi. The principal investigator is Yasemin Cirak, Prof. Dr. at Istinye University. The trial plans to enroll 32 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology